Details for New Drug Application (NDA): 050637
✉ Email this page to a colleague
NDA 050637 describes ZEFAZONE, which is a drug marketed by Pharmacia And Upjohn and is included in two NDAs. Additional details are available on the ZEFAZONE profile page.
The generic ingredient in ZEFAZONE is cefmetazole sodium. There are three drug master file entries for this compound. Additional details are available on the cefmetazole sodium profile page.
The generic ingredient in ZEFAZONE is cefmetazole sodium. There are three drug master file entries for this compound. Additional details are available on the cefmetazole sodium profile page.
Summary for 050637
| Tradename: | ZEFAZONE |
| Applicant: | Pharmacia And Upjohn |
| Ingredient: | cefmetazole sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050637
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Dec 11, 1989 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Dec 11, 1989 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
